WallStreetZenWallStreetZen

NASDAQ: PRPO
Precipio Inc Stock

$0.91-0.04 (-4.21%)
Updated Feb 3, 2023
PRPO Price
$0.91
Fair Value Price
$1.14
Market Cap
$20.77M
52 Week Low
$0.47
52 Week High
$1.77
P/E
-1.75x
P/B
1.14x
P/S
1.94x
PEG
N/A
Dividend Yield
N/A
Revenue
$9.46M
Earnings
-$12.12M
Gross Margin
27%
Operating Margin
-128.02%
Profit Margin
-128.2%
Debt to Equity
0.29
Operating Cash Flow
-$8M
Beta
0.77
Next Earnings
Mar 29, 2023
Ex-Dividend
N/A
Next Dividend
N/A

PRPO Overview

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PRPO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PRPO ($0.91) is undervalued by 19.89% relative to our estimate of its Fair Value price of $1.14 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
PRPO ($0.91) is not significantly undervalued (19.89%) relative to our estimate of its Fair Value price of $1.14 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
PRPO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PRPO due diligence checks available for Premium users.

Be the first to know about important PRPO news, forecast changes, insider trades & much more!

PRPO News

Valuation

PRPO fair value

Fair Value of PRPO stock based on Discounted Cash Flow (DCF)
Price
$0.91
Fair Value
$1.14
Undervalued by
19.89%
PRPO ($0.91) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PRPO ($0.91) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PRPO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PRPO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.75x
Industry
37.84x
Market
15.09x

PRPO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.14x
Industry
4.54x
PRPO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PRPO's financial health

Profit margin

Revenue
$2.2M
Net Income
-$3.2M
Profit Margin
-143.5%
PRPO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
PRPO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$23.5M
Liabilities
$5.3M
Debt to equity
0.29
PRPO's short-term assets ($7.42M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PRPO's short-term assets ($7.42M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PRPO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PRPO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.2M
Investing
-$119.0k
Financing
$31.0k
PRPO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PRPO vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
PRPO$20.77M-3.70%-1.75x1.14x
SLNO$21.13M-9.44%-0.78x1.39x
BIAF$19.92M-6.67%N/A1.58x
TRIB$22.36M-3.60%N/A3.37x
CHEK$24.75M+32.81%-0.97x0.55x

Precipio Stock FAQ

What is Precipio's quote symbol?

NASDAQ: PRPO) Precipio trades on the NASDAQ under the ticker symbol PRPO. Precipio stock quotes can also be displayed as NASDAQ: PRPO.

If you're new to stock investing, here's how to buy Precipio stock.

What is the 52 week high and low for Precipio (NASDAQ: PRPO)?

(NASDAQ: PRPO) Precipio's 52-week high was $1.77, and its 52-week low was $0.47. It is currently -48.59% from its 52-week high and 93.62% from its 52-week low.

How much is Precipio stock worth today?

(NASDAQ: PRPO) Precipio currently has 22,820,260 outstanding shares. With Precipio stock trading at $0.91 per share, the total value of Precipio stock (market capitalization) is $20.77M.

Precipio stock was originally listed at a price of $129,599.94 in Jul 18, 2000. If you had invested in Precipio stock at $129,599.94, your return over the last 22 years would have been -100%, for an annualized return of -41.69% (not including any dividends or dividend reinvestments).

How much is Precipio's stock price per share?

(NASDAQ: PRPO) Precipio stock price per share is $0.91 today (as of Feb 3, 2023).

What is Precipio's Market Cap?

(NASDAQ: PRPO) Precipio's market cap is $20.77M, as of Feb 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Precipio's market cap is calculated by multiplying PRPO's current stock price of $0.91 by PRPO's total outstanding shares of 22,820,260.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.